|
⚲
|
| Keyboard |
| BC SW LP
✚
|
|
|---|---|
| CIK # | 0001786351 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001786351] | |
| 3 | [0001786351] | |
| 4 | [0001786351] | |
| SC 13D | [0001786351] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| BC SW LP | Springworks Therapeutics Inc | [2019-09-24] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Schwartz Jeffrey Lawrence | |
| BC SW LP | |
| SpringWorks Therapeutics Inc | |
| Koppel Adam | |
| Bain Capital Life Sciences Investors LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2021-08-10 | Sell | 1,000,000 | $70.25 | 70,250,000 |
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2021-03-09 | Sell | 1,450,000 | $71.50 | 103,675,000 |
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Buy | 150,000 | $18.00 | 2,700,000 |
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Conversion | 1,053,204 | ||
|
SpringWorks Therapeutics Inc SWTX
Series B Convertible Preferred Stock · derivative
|
2019-09-17 | Conversion | 1,053,204 | ||
|
SpringWorks Therapeutics Inc SWTX
Series A Convertible Preferred Stock · derivative
|
2019-09-17 | Conversion | 6,078,103 | ||
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Conversion | 6,078,103 |